Lantern Pharma Inc. – NASDAQ:LTRN

Lantern Pharma stock price today

$4.25
+0.83
+24.27%
Financial Health
0
1
2
3
4
5
6
7
8
9

Lantern Pharma stock price monthly change

-22.62%
month

Lantern Pharma stock price quarterly change

-22.62%
quarter

Lantern Pharma stock price yearly change

-14.29%
year

Lantern Pharma key metrics

Market Cap
32.46M
Enterprise value
17.64M
P/E
-3.71
EV/Sales
N/A
EV/EBITDA
-1.25
Price/Sales
N/A
Price/Book
0.97
PEG ratio
0.23
EPS
-1.63
Revenue
N/A
EBITDA
-19.26M
Income
-17.53M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Lantern Pharma stock price history

Lantern Pharma stock forecast

Lantern Pharma financial statements

Lantern Pharma Inc. (NASDAQ:LTRN): Profit margin
Jun 2023 0 -4.74M
Sep 2023 0 -3.16M
Dec 2023 261.05K -4.18M -1603.48%
Mar 2024 0 -5.44M
Lantern Pharma Inc. (NASDAQ:LTRN): Analyst Estimates
2025 0 -27.65M
2026 1.95M -18.58M -953.23%
2027 14.6M -13.87M -95.06%
2028 33.8M -9.10M -26.95%
  • Analysts Price target

  • Financials & Ratios estimates

Lantern Pharma Inc. (NASDAQ:LTRN): Debt to assets
Jun 2023 51426024 3.16M 6.16%
Sep 2023 47771508 2.35M 4.94%
Dec 2023 43647616 2.73M 6.28%
Mar 2024 39734224 3.96M 9.99%
Lantern Pharma Inc. (NASDAQ:LTRN): Cash Flow
Jun 2023 -3.59M -457.24K -690.79K
Sep 2023 -3.61M 231.72K 0
Dec 2023 -3.38M 256.18K -499.99K
Mar 2024 -3.06M -556.16K 54.71K

Lantern Pharma alternative data

Lantern Pharma Inc. (NASDAQ:LTRN): Employee count
Aug 2023 22
Sep 2023 22
Oct 2023 22
Nov 2023 22
Dec 2023 22
Jan 2024 22
Feb 2024 22
Mar 2024 21
Apr 2024 21
May 2024 21
Jun 2024 21
Jul 2024 21

Lantern Pharma other data

5.57% -4.21%
of LTRN is owned by hedge funds
607.09K -459.33K
shares is hold by hedge funds

Lantern Pharma Inc. (NASDAQ:LTRN): Insider trades (number of shares)
Period Buy Sel
Nov 2023 0 290696
Jan 2024 0 117778
Feb 2024 0 288000
May 2024 0 60000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 13,888 $6.33 $87,911
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 4,253 $6.33 $26,921
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 1,859 $6.33 $11,767
Sale
FLETCHER AARON G.L. 10 percent owner
Common Stock 13,888 $6.33 $87,911
Sale
FLETCHER AARON G.L. 10 percent owner
Common Stock 4,253 $6.33 $26,921
Sale
FLETCHER AARON G.L. 10 percent owner
Common Stock 1,859 $6.33 $11,767
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 6,944 $6.25 $43,400
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 2,126 $6.25 $13,288
Sale
KREIS LESLIE W. 10 percent owner
Common Stock 930 $6.25 $5,813
Sale
FLETCHER AARON G.L. 10 percent owner
Common Stock 6,944 $6.25 $43,400
Patent
Application
Filling date: 8 Sep 2021 Issue date: 2 Jun 2022
Application
Filling date: 14 Apr 2021 Issue date: 29 Jul 2021
Application
Filling date: 4 Mar 2021 Issue date: 1 Jul 2021
Monday, 9 December 2024
businesswire.com
Tuesday, 3 December 2024
businesswire.com
Tuesday, 26 November 2024
businesswire.com
Friday, 8 November 2024
seekingalpha.com
Thursday, 7 November 2024
businesswire.com
Tuesday, 5 November 2024
businesswire.com
Thursday, 31 October 2024
businesswire.com
Wednesday, 23 October 2024
businesswire.com
Tuesday, 15 October 2024
businesswire.com
Monday, 23 September 2024
businesswire.com
Saturday, 10 August 2024
seekingalpha.com
Wednesday, 12 June 2024
businesswire.com
Thursday, 23 May 2024
investorplace.com
Thursday, 9 May 2024
businesswire.com
Monday, 6 May 2024
businesswire.com
Thursday, 2 May 2024
businesswire.com
Wednesday, 1 May 2024
InvestorPlace
Monday, 18 March 2024
Seeking Alpha
Monday, 11 March 2024
Business Wire
Wednesday, 13 December 2023
InvestorPlace
Thursday, 9 November 2023
Seeking Alpha
Thursday, 14 September 2023
InvestorPlace
Monday, 28 August 2023
InvestorPlace
Wednesday, 23 August 2023
InvestorPlace
Wednesday, 16 August 2023
InvestorPlace
Wednesday, 9 August 2023
Seeking Alpha
InvestorPlace
Tuesday, 8 August 2023
InvestorPlace
Wednesday, 2 August 2023
InvestorPlace
Tuesday, 1 August 2023
InvestorPlace
  • What's the price of Lantern Pharma stock today?

    One share of Lantern Pharma stock can currently be purchased for approximately $4.25.

  • When is Lantern Pharma's next earnings date?

    Unfortunately, Lantern Pharma's (LTRN) next earnings date is currently unknown.

  • Does Lantern Pharma pay dividends?

    No, Lantern Pharma does not pay dividends.

  • How much money does Lantern Pharma make?

    Lantern Pharma has a market capitalization of 32.46M.

  • What is Lantern Pharma's stock symbol?

    Lantern Pharma Inc. is traded on the NASDAQ under the ticker symbol "LTRN".

  • What is Lantern Pharma's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Lantern Pharma?

    Shares of Lantern Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Lantern Pharma's key executives?

    Lantern Pharma's management team includes the following people:

    • Mr. Panna Sharma Pres, Chief Executive Officer & Director(age: 54, pay: $750,490)
    • Mr. David R. Margrave Chief Financial Officer & Sec.(age: 64, pay: $298,880)
    • Dr. Kishor Gopaldas Bhatia Ph.D. Chief Scientific Officer & Scientific Consultant(age: 70, pay: $92,890)
  • How many employees does Lantern Pharma have?

    As Jul 2024, Lantern Pharma employs 21 workers.

  • When Lantern Pharma went public?

    Lantern Pharma Inc. is publicly traded company for more then 5 years since IPO on 11 Jun 2020.

  • What is Lantern Pharma's official website?

    The official website for Lantern Pharma is lanternpharma.com.

  • Where are Lantern Pharma's headquarters?

    Lantern Pharma is headquartered at 1920 McKinney Avenue, Dallas, TX.

  • How can i contact Lantern Pharma?

    Lantern Pharma's mailing address is 1920 McKinney Avenue, Dallas, TX and company can be reached via phone at +972 2771136.

Lantern Pharma company profile:

Lantern Pharma Inc.

lanternpharma.com
Exchange:

NASDAQ

Full time employees:

21

Industry:

Biotechnology

Sector:

Healthcare

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-300 as a combination therapy for non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

1920 McKinney Avenue
Dallas, TX 75201

CIK: 0001763950
ISIN: US51654W1018
CUSIP: 51654W101